Supernus Pharmaceuticals | SUPN - Marktkapitalisierung

Aktienkurs
49.77
Täglich Wechseln
-1.05 -2.07%
Monatlich
-0.86%
Jährlich
54.18%
Q1 Prognose
48.40




Marktkapitalisierung Veränderung Datum
Abbott USD 217.86B 15.25B 2025-12
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Aurora Cannabis CAD 470.14M 146.16M 2025-09
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Canopy Growth CAD 781.35M 426.11M 2025-09
Cara Therapeutics USD 28M 11M 2024-12
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Xeris Pharmaceuticals USD 1.32B 562M 2025-09